Until now, researchers thought that the development of the human brain's visual-processing center stopped in the first few years of life. But a new study challenges this belief, instead suggesting that vision develops until midlife. This may have a significant impact on people with amblyopia, which is an eye disorder that causes what is commonly known as a "lazy eye."
A new study, published in the Journal of Neuroscience, suggests that human vision might take longer to develop than previously thought.
A team of researchers led by Kathryn Murphy, a professor in the Department of Psychology, Neuroscience and Behaviour at McMaster University in Ontario, Canada, set out to examine the evolution of the primary visual cortex in the human brain by analyzing the postmortem brain tissue of 30 people, ranging in age from 20 days to 80 years.
Until now, the accepted view has been that in humans, the maturation of the primary visual cortex is completed in the first few years of life.
This traditional belief was based on anatomical studies of how the synapses are formed, as well as how connections within the cortex and between the cortex and other brain regions occur.
However, Murphy and colleagues have previously discovered that there are some proteins in the primary visual cortex that continue to develop well beyond the first years of life.
Their new study confirms these preliminary findings.
In their previous research, Murphy and colleagues looked at the so-called GABAergic activity in the brain. GABA stands for gamma-aminobutyric acid, and "GABAergic" refers to the brain's ability to produce it.
GABA is a neurotransmitter whose main function is to inhibit the action of another neurotransmitter called glutamate.
Their former study looked at the balance between excitation and inhibition in the brain, and how it is linked to the plasticity and aging of the visual cortex. The researchers followed the maturation of this brain region and showed how these GABAergic mechanisms change across the human lifespan.
This previous research showed that the GABA-producing mechanisms continue to mature until quite late in life. However, it still was not clear whether all of the mechanisms that regulate the plasticity of the synapses behaved in the same way. GABA is inhibitory, but what about the excitatory neurotransmitters and synapses?
As Murphy and colleagues explain in their new paper, over 80 percent of synapses in the primary visual cortex are excitatory.
So, to answer this question, the scientists looked at the postmortem tissue of 30 people, of whom 12 were females and 18 were males. They examined their brain tissue using Western blotting - a technique commonly used in molecular biology to separate and identify specific proteins from the mixture of proteins that has been extracted from cells.
The researchers found that some of the glutamatergic proteins - that is, the ones that produce the excitatory glutamate - develop until late childhood, but others develop until around the age of 40.
According to the new research, the visual-processing part of the brain matures until a person reaches 36 years of age, plus or minus around 4.5 years.
This was surprising, as the consensus is that the primary visual cortex stops developing at around the age of 5 or 6 years.
Additionally, the researchers found that the primary visual cortex develops gradually across five stages, which reflect "life-long changes in human visual perception."
"There's a big gap in our understanding of how our brains function. Our idea of sensory areas developing in childhood and then being static is part of the challenge. It's not correct."
Prof. Kathryn Murphy
These findings may have significant implications for conditions such as amblyopia, which is more popularly known as "lazy eye." Currently, medical professionals only prescribe corrective therapies to children who have amblyopia. It is currently estimated that "approximately 2 to 3 out of every 100 children" are affected by amblyopia in the United States.
Treating adults is considered futile, as their visual cortex is thought not to be plastic or respond to treatment anymore. However, Murphy says that their research suggests that more brain areas are more flexible and responsive to experience-dependent plasticity than previously thought.
Learn how blind people's brains rewire to improve other senses.
Excerpt from:
Eyesight continues to develop until your 40s, new study finds - Medical News Today
- Seeing Is Believing: The Gene Therapy Breakthrough Thats Giving Sight to the Blind - SciTechDaily - September 21st, 2024
- VisiActive Review: The Natural Approach to Enhancing Your Vision and Eye Care - Bellevue Reporter - September 21st, 2024
- Does VisiActive Work? An Honest Review of Its Eye Health Claims - Kirkland Reporter - September 21st, 2024
- Sharp eye test: Only those with a perfect vision can spot the third dog in the picture - The Times of India - September 21st, 2024
- Does X Vision Really Work? An Honest Review of Its Eye Health Benefits - Islands' Sounder - September 21st, 2024
- VisiActive Review: Is This the Ultimate Supplement for Clearer, Healthier Vision? - Vashon-Maury Island Beachcomber - September 21st, 2024
- New Report Recommends Myopia Be Classified as a Disease, Policies for Children to Spend Time Outdoors - National Academies of Sciences, Engineering,... - September 21st, 2024
- X Vision Review: How Effective Is This Supplement for Enhancing Vision and Eye Health? - Kirkland Reporter - September 21st, 2024
- Elon Musk's Neuralink is working on a product called Blindsight that can restore vision: story in 5 points - India Today - September 21st, 2024
- How the eyes are windows into our health and why we should get them tested - South China Morning Post - September 21st, 2024
- UK research finds lower rate of GOS sight test activity in areas of deprivation - AOP - September 21st, 2024
- Dudley residents urged to keep an eye on their optic health - Dudley News - September 21st, 2024
- Test your eyesight: Find the odd red plane in under 7 seconds - The Times of India - August 7th, 2024
- You have 20/20 vision if you can find the hidden chick amongst these ducks - IndiaTimes - December 30th, 2023
- How to watch the solar eclipse without damaging your eyesight - WATE 6 On Your Side - October 16th, 2023
- Can Optical Illusions Improve Vision? Know The Best One That Benefits Eyesight - Times Now - May 17th, 2023
- Motus GI Announces Executive Leadership Restructuring and Additional Cost Saving Initiatives to Support Near-Term Milestones - April 15th, 2023
- Revolution Medicines to Participate in 22nd Annual Needham Healthcare Conference - April 15th, 2023
- GENFIT Reports Full-Year 2022 Financial Results and Provides Corporate Update - April 15th, 2023
- Kane Biotech to Release Fourth Quarter and Full Year 2022 Financial Results on April 20, 2023 – Conference Call to Follow - April 15th, 2023
- Biomea Fusion To Present Two Preclinical Posters at the 114th AACR Annual Meeting - April 15th, 2023
- Cabaletta Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference - April 15th, 2023
- Syneos Health Schedules First Quarter 2023 Earnings Call for Wednesday, May 10th, 2023 - April 15th, 2023
- Oncternal Therapeutics Participating in Oppenheimer & Co.’s Virtual Fireside Chat: Discussion of ROR1 CAR T Cell Therapy in Hematological... - April 15th, 2023
- Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 15th, 2023
- Alvotech Provides Regulatory Update on AVT02 Biologics License Application - April 15th, 2023
- Vivoryon Therapeutics N.V. to Report Full Year 2022 Financial Results and Operational Progress on April 19, 2023 - April 15th, 2023
- Additional Future Royalty Revenue Stream for Nicox from 2024 following New Drug Application Submission for ZERVIATE in China - April 15th, 2023
- Ultimovacs ASA – Disclosure of voting rights of Annual General Meeting - April 15th, 2023
- QIAGEN showcases latest technologies to advance cancer research at AACR Annual Meeting 2023 - April 15th, 2023
- ITM lädt zu Symposium und Messestand auf der Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin in Leipzig ein - April 15th, 2023
- International Carrot Day: From healthy eyesight to weight loss - 5 wonderful benefits of carrot - Zee Business - April 7th, 2023
- How the Human Eye Works | Cornea Layers/Role | Light Rays - NKCF.org - December 11th, 2022
- Eye Emergencies: Types, Symptoms, and Prevention - Healthline - November 25th, 2022
- The criteria for certification | RNIB - November 25th, 2022
- Foresight: Eye-Net Successfully Showcases its Advanced Solution to Leading OEMs and Tier One Suppliers in Japan - Marketscreener.com - November 25th, 2022
- Can you see me now? Average person begins worrying about their vision at age 39 - Study Finds - September 29th, 2022
- Contact lens wearers at higher risk of rare eye infection are you caring for your lenses the right way? - News24 - September 29th, 2022
- A man who popped a champagne cork into his eye says it felt like being poked 'times a thousand.' His vision was saved after months of treatment but it... - September 29th, 2022
- Whitsett Vision Group First to Use Revolutionary New Lens to Dramatically Improve Patients' Eyesight - PR Newswire - September 29th, 2022
- 'As one door closes, another opens': Adelaide man turned to yoga, meditation after major vision loss - SBS - September 29th, 2022
- Stephen Curry, whose $185,000 worth vehicle almost took his life, is sure to lose his eyesight due to a genetic defect - The Sportsrush - September 29th, 2022
- NCCVEH Names Dr. Donny W. Suh, Gavin Herbert Eye Institute, UC Irvine, as Recipient of the 8th Annual Bonnie Strickland Champion for Children's Vision... - September 29th, 2022
- XP Health Raises $17.1M Series A to Transform Vision Benefits for Insurance Carriers, Companies and Employees - PR Web - September 29th, 2022
- Everything You Need To Know About Ocular Herpes Zoster: Symptoms, Treatment, And Complications - World Nation News - September 29th, 2022
- Blurry vision turned out be tumour behind Exeter woman's eye - Devon Live - April 26th, 2022
- Woman who lost half her body weight sheds the stones for second time after sight loss - Yahoo News - April 26th, 2022
- High Schooler's Nausea Turned Out To Be Aggressive and Deadly Brain Tumor - Newsweek - April 26th, 2022
- BattleVision Storm Glasses Sees Uptick in Sales as Winter Hits - Benzinga - Benzinga - January 1st, 2022
- Insights on the Eye Care Surgical Global Market to 2026 - Featuring Abbott Laboratories, Alcon Vision and Avedro Among Others - PRNewswire - January 1st, 2022
- Monocular vision (sight in one eye) - RNIB - See differently - November 21st, 2021
- See which of your habits is actually hurting your eyesight - Yahoo News UK - November 21st, 2021
- CVRS, TEH protect the gift of sight with free eye surgeries | Loop Trinidad & Tobago - Loop News Trinidad and Tobago - November 21st, 2021
- Take More Walking to Improve Your Eyesight! - Central Recorder - November 21st, 2021
- Remedies to reduce eye strain while working from home - The Siasat Daily - November 21st, 2021
- Chris McCausland: 'I was diagnosed with retinitis pigmentosa' what is that? - Daily Express - November 21st, 2021
- 5th Graders help Pittsburg Lions Club improve vision for those in need Newstalk KZRG - newstalkkzrg.com - November 21st, 2021
- Uptick in vision problems among children could be due to screen time - Wink News - November 21st, 2021
- Lindsay Senior With Worsening Eyesight Urges Government And Optometrists To Resume OHIP Eye Care - Kawartha 411 - November 21st, 2021
- The Link Between Loneliness and Vision Impairment on Dementia - DocWire News - November 21st, 2021
- Optometrist warns of the long-term effects drinking can have on your eyes - Daily Express - November 21st, 2021
- Horizon Therapeutics Recognizes Second Annual Thyroid Eye Disease (TED) Awareness Week with New Educational and Community Building Initiative -... - November 21st, 2021
- Jumping spiders: Facts about the cutest arachnids on the planet - Livescience.com - November 21st, 2021
- Need a Boost on Your Eye Exam? Study Provides Early Evidence that Cocoa Sharpens Vision for Adults with Healthy Eyes - One Green Planet - July 21st, 2021
- How to Use Your iPhone to Check Eyesight and Renew Your Prescription - TechTheLead - July 21st, 2021
- 10 foods that are good for kids' eyesight - Free Press Journal - July 21st, 2021
- Reduce Eye Strain While Working From Home: Ayurveda Remedies To Deal With Computer Vision Syndrome - TheHealthSite - July 21st, 2021
- Prevent Blindness Holds 'Focus on Eye Health' National Summit - InvisionMag - July 21st, 2021
- Eye problems on the rise in India amid Covid-19 pandemic - Free Press Journal - July 21st, 2021
- Sean Moncrieff: I felt useless, frustrated and guilty after my operation - The Irish Times - July 21st, 2021
- Three Things Patients Should Know About Cataracts - Oregon Business - July 21st, 2021
- Johnson & Johnson Vision Presents Scientific Data Validating Improved Surgical Outcomes With Latest Cataract Innovations And Legacy MGD Treatment... - July 21st, 2021
- Sydney Optometrist Mosman Eye Injury Protection Vision Therapy Myopia Prevention - PRWire - July 21st, 2021
- EssilorLuxottica and the FIA reinforce their commitment to promote good vision for safer roads - GlobeNewswire - July 21st, 2021
- Genes from algae helped a blind man recover some of his vision - Livescience.com - May 27th, 2021
- Blind man regains some vision, with help from light-sensing algal protein - Science Magazine - May 27th, 2021
- Top paratriathlete carries the torch for healthy vision to Tokyo - liherald - May 27th, 2021
- A First: Blind Man's Sight Restored With Optogenetic Therapy - Medscape - May 27th, 2021
- Scientists successfully use gene therapy to restore eyesight restore eyesight, gene therapy - Open Access Government - May 27th, 2021
- What We're Reading: Restoring Eyesight; New Moderna Vaccine Indication Possible; COVID-19 Origin Investigation - AJMC.com Managed Markets Network - May 27th, 2021